相似文献
1
Pfizer accused of testing new drug without ethical approval.
BMJ. 2001 Jan 27;322(7280):194.
2
Human research. Nigerian families sue Pfizer, testing the reach of U.S. law.
Science. 2001 Sep 7;293(5536):1742. doi: 10.1126/science.293.5536.1742.
3
Pfizer settles with victims of Nigerian drug trial.
BMJ. 2011 Aug 16;343:d5268. doi: 10.1136/bmj.d5268.
4
Pfizer in "unethical" trial suit.
Nat Med. 2001 Oct;7(10):1077. doi: 10.1038/nm1001-1077c.
5
Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration.
Dev World Bioeth. 2010 Apr;10(1):1-10. doi: 10.1111/j.1471-8847.2008.00239.x. Epub 2008 Jul 28.
6
Nigerian judge orders arrests of Pfizer officials.
BMJ. 2008 Jan 5;336(7634):11. doi: 10.1136/bmj.39444.446725.DB.
7
Drug company sued over research trial in Nigeria.
Lancet. 2001 Sep 8;358(9284):815. doi: 10.1016/S0140-6736(01)06011-1.
8
Appeals court rules that Nigerian families can sue Pfizer in US.
BMJ. 2009 Feb 6;338:b458. doi: 10.1136/bmj.b458.
9
Trials and errors: with drug companies now testing new medicines in all parts of the globe, are ethical standards being compromised?
New Sci. 2003 Jun 21;178(2400):28.
10
Pfizer lawsuit spotlights ethics of developing world clinical trials.
Nat Med. 2007 Jul;13(7):763. doi: 10.1038/nm0707-763. Epub 2007 Jun 29.
引用本文的文献
1
Developing a master of science in health research ethics program in Northern Nigeria: a needs assessment.
BMC Med Ethics. 2025 Feb 8;26(1):24. doi: 10.1186/s12910-025-01165-w.
2
Reporting ethical approval in case reports and case series in 12 consecutive years: A systematic review.
Health Care Sci. 2024 Oct 4;3(5):298-311. doi: 10.1002/hcs2.113. eCollection 2024 Oct.
3
Approaches to enable equitable psychiatric genetic research in Africa.
Commun Med (Lond). 2024 Oct 25;4(1):216. doi: 10.1038/s43856-024-00639-z.
4
The Role of Sudanese Doctors in the United Kingdom in Mitigating COVID-19 Vaccine Hesitancy Among Their Diaspora Communities.
Glob Health Sci Pract. 2023 Jun 21;11(3). doi: 10.9745/GHSP-D-22-00447.
5
The experience of disproportionate supplies of COVID-19 vaccines to Africa: the need for Africa to decolonize its public health response.
Pan Afr Med J. 2023 Jan 27;44:54. doi: 10.11604/pamj.2023.44.54.37737. eCollection 2023.
6
Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations.
Adv Ther. 2023 May;40(5):2147-2185. doi: 10.1007/s12325-023-02492-3. Epub 2023 Apr 5.
7
COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons.
Vaccine. 2023 Apr 6;41(15):2476-2484. doi: 10.1016/j.vaccine.2023.02.056. Epub 2023 Feb 23.
8
Ethical Relativism and Circumstances of Social and Cultural Contingencies on Informed Consent in the Conduct of Research: Clinical Trials in Nigeria.
Asian Bioeth Rev. 2022 Oct 13;15(1):37-52. doi: 10.1007/s41649-022-00223-4. eCollection 2023 Jan.
9
"The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom.
PLoS One. 2022 Sep 9;17(9):e0273687. doi: 10.1371/journal.pone.0273687. eCollection 2022.
10
Why do people consent to receiving SARS-CoV-2 vaccinations? A representative survey in Germany.
BMJ Open. 2022 Aug 18;12(8):e060555. doi: 10.1136/bmjopen-2021-060555.
Zotero 插件